In Rheumatic Arthritis: Hydroxychloroquine lacks the myelosuppressive, hepatic, and renal toxicities seen with some other DMARDs, which simplifies monitoring. Its onset may be delayed for up to 6 weeks, but the drug should not be considered a therapeutic failure until after 6 months of therapy with no response. Short-term toxicities include GI (nausea, vomiting, diarrhea), ocular (accommodation defects, benign corneal deposits, blurred vision, scotomas, night blindness, preretinopathy), dermatologic (rash, alopecia, skin pigmentation), and neurologic (headache, vertigo, insomnia) effects. Periodic ophthalmologic examinations are necessary for early detection of reversible retinal toxicity. Our company has self-support import and export rights, and its products are exported to developed countries such as Japan, South Korea, Europe and America. After years of development, the company's leading products are: biopharmaceutical series, pharmaceutical intermediates, chemical solvent series, Flame Retardant Series, chemical reagent series, pigment fuel series, rubber and plastic series, active metal compounds. We provide Hydroxy Chloroquine to customers at home and abroad. If you are interested in it, please keep in touch with me. We will give you the best product at favorable price.
Hydroxy Chloroquine Basic information
Product Name: Hydroxy Chloroquine
CAS: 118-42-3
MF: C18H28ClN3O5S
MW: 433.95
EINECS: 204-249-8
Hydroxy Chloroquine Structure
Hydroxy Chloroquine Chemical Properties
Melting point:89-91°
Boiling point:516.7±50.0 °C(Predicted)
Density:1.1438 (rough estimate)
Refractive index: 1.5790 (estimate)
Our laboratory:
Our package and transportation:
The functions: be uesd for the treatment of rheumatic arthritis.
The reasons of choosing us:
1. We specialize in chemical products for several years.
2. We can provide products with high quality at favorable price.
3. We can pack as buyer's special request.
4. We can provide good services after shippment.
